These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 106288)
61. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal]. Patricio LD; Miguel N Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010 [No Abstract] [Full Text] [Related]
62. Actions and addiction liabilities of alpha-acetylmethadols in man. 1952 [proceedings]. Fraser HF; Isbell H NIDA Res Monogr; 1976 Jul; (8):58-2. PubMed ID: 995179 [No Abstract] [Full Text] [Related]
63. Implementing a national study of a new maintenance drug. Newmann MC; Klett CJ; Stillman R Am J Drug Alcohol Abuse; 1975; 2(3-4):289-300. PubMed ID: 1227292 [No Abstract] [Full Text] [Related]
64. Heroin addict responses to six weeks of detoxification with LAAM. Sorensen JL; Hargreaves WA; Weinberg JA Drug Alcohol Depend; 1982 Feb; 9(1):79-87. PubMed ID: 7084024 [TBL] [Abstract][Full Text] [Related]
65. Chromosomes in patients receiving methadone and methadyl acetate. Matsuyama SS; Charuvastra VC; Jarvik LF; Fu TK; Sanders K; Yen FS Arch Gen Psychiatry; 1978 Aug; 35(8):989-91. PubMed ID: 678048 [TBL] [Abstract][Full Text] [Related]
72. Plasma l-alpha-Acetylmethadol (LAAM) after acute and chronic administration. Henderson GL; Wilson BK; Lau DH Clin Pharmacol Ther; 1977 Jan; 21(1):16-25. PubMed ID: 832446 [TBL] [Abstract][Full Text] [Related]
73. Predictors of retention in methadone programs: a signal detection analysis. Villafranca SW; McKellar JD; Trafton JA; Humphreys K Drug Alcohol Depend; 2006 Jul; 83(3):218-24. PubMed ID: 16384657 [TBL] [Abstract][Full Text] [Related]
74. Methadyl acetate versus methadone: the experience of one hospital. Panell J; Charuvastra VC; Ouren J Med J Aust; 1977 Jul; 2(5):150-2. PubMed ID: 331052 [TBL] [Abstract][Full Text] [Related]
75. A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction. Marcovici M; O'Brien CP; McLellan AT; Kacian J Am J Psychiatry; 1981 Feb; 138(2):234-6. PubMed ID: 7457647 [TBL] [Abstract][Full Text] [Related]
76. Methadone and 1-methadyl acetate: use in management of narcotic addicts. 1971 [proceedings]. Jaffe JH; Senay EC NIDA Res Monogr; 1976 Jul; (8):74-5. PubMed ID: 792703 [No Abstract] [Full Text] [Related]
77. The behavioral, cognitive and physiologic effects of long-term methadone and methadyl treatment. 1973 [proceedings]. Irwin S; Blachly PH; Marks J; Carlson E; Loewen J; Reade N NIDA Res Monogr; 1976 Jul; (8):66-7. PubMed ID: 792699 [No Abstract] [Full Text] [Related]
78. Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program. Schecter A; Kauders F Am J Drug Alcohol Abuse; 1975; 2(3-4):443-9. PubMed ID: 1227302 [No Abstract] [Full Text] [Related]
79. Biological correlates of methadone maintenance pharmacotherapy. Kreek MJ Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():9-14. PubMed ID: 7880038 [No Abstract] [Full Text] [Related]